APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Protease

A protease (also called a peptidase or proteinase) is an enzyme that catalyzes (increases the rate of) proteolysis, the breakdown of proteins into smaller polypeptides or single amino acids. They do this by cleaving the peptide bonds within proteins by hydrolysis, a reaction where water breaks bonds.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

A protease (also called a peptidase or proteinase) is an enzyme that catalyzes (increases the rate of) proteolysis, the breakdown of proteins into smaller polypeptides or single amino acids. They do this by cleaving the peptide bonds within proteins by hydrolysis, a reaction where water breaks bonds.

Selected research

Market Outlook & Growth Opportunities

Global Protease Market Outlook and Growth Opportunities 2026

Report ID 173341050427 December 2025198 pages

Choose your research edition.

Industry ResearchProtease Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Protease Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Protease Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Protease Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Protease Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

A protease (also called a peptidase or proteinase) is an enzyme that catalyzes (increases the rate of) proteolysis, the breakdown of proteins into smaller polypeptides or single amino acids. They do this by cleaving the peptide bonds within proteins by hydrolysis, a reaction where water breaks bonds.

Market concentration for protease production is high, Novozymes A/S, DuPont (Danisco), Amano Enzymes, Inc., DSM and AB Enzymes occupied over 55% market share in 2019, and Novozymes A/S is the biggest player which took about 13.59% sales share and 15.49% revenue share in 2019, DuPont (Danisco) and Amano Enzymes, Inc. followed with 13.01% and 9.48% revenue share in 2019. Other significant players include BASF, Aum Enzymes, Jiangsu Boli Bioproducts Co., Ltd, Specialty Enzymes & Biotechnologies Co. and a few others.

This report provides an overview of the global Protease market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

Read the full market overview

The study covers key producers of Protease and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Protease sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Protease market size, projected growth trends, production technologies, key applications, and end-use industries.

Protease Segment by Company

Novozymes A/S

DuPont (Danisco)

AB Enzymes

DSM

Aum Enzymes

BASF

Specialty Enzymes & Biotechnologies Co.

Jiangsu Boli Bioproducts Co., Ltd

Amano Enzymes, Inc.

Protease Segment by Type

Microbial Source

Plant Source

Animal Source

Protease Segment by Application

Industry

Medicine

Basic Biological Research Tool

Protease Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Protease status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Protease market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Protease significant trends, drivers, influence factors in global and regions.

6. To analyze Protease competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Protease market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Protease and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Protease.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Protease market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Protease industry.

Chapter 3: Detailed analysis of Protease manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Protease in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Protease in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Protease Industry Trends Table 2. Protease Industry Drivers Table 3. Protease Industry Opportunities and Challenges Table 4. Protease Industry Restraints Table 5. Global Protease Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Protease Revenue Share by Company (2021-2026) Table 7. Global Protease Sales Volume by Company (Tons) & (2021-2026) Table 8. Global Protease Sales Volume Share by Company (2021-2026) Table 9. Global Protease Average Price (US$/Ton) of Company (2021-2026) Table 10. Global Protease Company Ranking, (2024-2026) & (USD Million) Table 11. Global Protease Key Company Manufacturing Base & Headquarters Table 12. Global Protease Company, Product Type & Application Table 13. Global Protease Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Protease by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Microbial Source Table 18. Significant Companies of Plant Source Table 19. Significant Companies of Animal Source Table 20. Global Protease Sales Volume by Type 2021 VS 2025 VS 2032 (Tons) Table 21. Global Protease Sales Volume by Type (2021-2026) & (Tons) Table 22. Global Protease Sales Volume by Type (2027-2032) & (Tons) Table 23. Global Protease Sales Volume Share by Type (2021-2026) Table 24. Global Protease Sales Volume Share by Type (2027-2032) Table 25. Global Protease Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Protease Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Protease Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Protease Sales Value Share by Type (2021-2026) Table 29. Global Protease Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Industry Table 31. Significant Companies of Medicine Table 32. Significant Companies of Basic Biological Research Tool Table 33. Global Protease Sales Volume by Application 2021 VS 2025 VS 2032 (Tons) Table 34. Global Protease Sales Volume by Application (2021-2026) & (Tons) Table 35. Global Protease Sales Volume by Application (2027-2032) & (Tons) Table 36. Global Protease Sales Volume Share by Application (2021-2026) Table 37. Global Protease Sales Volume Share by Application (2027-2032) Table 38. Global Protease Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Protease Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Protease Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Protease Sales Value Share by Application (2021-2026) Table 42. Global Protease Sales Value Share by Application (2027-2032) Table 43. Global Protease Sales by Region: 2021 VS 2025 VS 2032 (Tons) Table 44. Global Protease Sales by Region (2021-2026) & (Tons) Table 45. Global Protease Sales Market Share by Region (2021-2026) Table 46. Global Protease Sales by Region (2027-2032) & (Tons) Table 47. Global Protease Sales Market Share by Region (2027-2032) Table 48. Global Protease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Protease Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Protease Sales Value Share by Region (2021-2026) Table 51. Global Protease Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Protease Sales Value Share by Region (2027-2032) Table 53. Global Protease Market Average Price (US$/Ton) by Region (2021-2026) Table 54. Global Protease Market Average Price (US$/Ton) by Region (2027-2032) Table 55. Global Protease Sales by Country: 2021 VS 2025 VS 2032 (Tons) Table 56. Global Protease Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Protease Sales by Country (2021-2026) & (Tons) Table 58. Global Protease Sales Market Share by Country (2021-2026) Table 59. Global Protease Sales by Country (2027-2032) & (Tons) Table 60. Global Protease Sales Market Share by Country (2027-2032) Table 61. Global Protease Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Protease Sales Value Market Share by Country (2021-2026) Table 63. Global Protease Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Protease Sales Value Market Share by Country (2027-2032) Table 65. Novozymes A/S Company Information Table 66. Novozymes A/S Business Overview Table 67. Novozymes A/S Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 68. Novozymes A/S Protease Product Portfolio Table 69. Novozymes A/S Recent Development Table 70. DuPont (Danisco) Company Information Table 71. DuPont (Danisco) Business Overview Table 72. DuPont (Danisco) Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 73. DuPont (Danisco) Protease Product Portfolio Table 74. DuPont (Danisco) Recent Development Table 75. AB Enzymes Company Information Table 76. AB Enzymes Business Overview Table 77. AB Enzymes Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 78. AB Enzymes Protease Product Portfolio Table 79. AB Enzymes Recent Development Table 80. DSM Company Information Table 81. DSM Business Overview Table 82. DSM Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 83. DSM Protease Product Portfolio Table 84. DSM Recent Development Table 85. Aum Enzymes Company Information Table 86. Aum Enzymes Business Overview Table 87. Aum Enzymes Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 88. Aum Enzymes Protease Product Portfolio Table 89. Aum Enzymes Recent Development Table 90. BASF Company Information Table 91. BASF Business Overview Table 92. BASF Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 93. BASF Protease Product Portfolio Table 94. BASF Recent Development Table 95. Specialty Enzymes & Biotechnologies Co. Company Information Table 96. Specialty Enzymes & Biotechnologies Co. Business Overview Table 97. Specialty Enzymes & Biotechnologies Co. Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 98. Specialty Enzymes & Biotechnologies Co. Protease Product Portfolio Table 99. Specialty Enzymes & Biotechnologies Co. Recent Development Table 100. Jiangsu Boli Bioproducts Co., Ltd Company Information Table 101. Jiangsu Boli Bioproducts Co., Ltd Business Overview Table 102. Jiangsu Boli Bioproducts Co., Ltd Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 103. Jiangsu Boli Bioproducts Co., Ltd Protease Product Portfolio Table 104. Jiangsu Boli Bioproducts Co., Ltd Recent Development Table 105. Amano Enzymes, Inc. Company Information Table 106. Amano Enzymes, Inc. Business Overview Table 107. Amano Enzymes, Inc. Protease Sales (Tons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2021-2026) Table 108. Amano Enzymes, Inc. Protease Product Portfolio Table 109. Amano Enzymes, Inc. Recent Development Table 110. Key Raw Materials Table 111. Raw Materials Key Suppliers Table 112. Protease Distributors List Table 113. Protease Customers List Table 114. Research Programs/Design for This Report Table 115. Authors List of This Report Table 116. Secondary Sources Table 117. Primary Sources List of Figures Figure 1. Protease Product Image Figure 2. Global Protease Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Protease Sales Value (2021-2032) & (US$ Million) Figure 4. Global Protease Sales (2021-2032) & (Tons) Figure 5. Global Protease Sales Average Price (US$/Ton) & (2021-2032) Figure 6. Global Protease Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Microbial Source Image Figure 10. Plant Source Image Figure 11. Animal Source Image Figure 12. Global Protease Sales Volume by Type (2021 VS 2025 VS 2032) & (Tons) Figure 13. Global Protease Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Protease Sales Volume Share by Type (2021-2032) Figure 15. Global Protease Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Protease Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Protease Sales Value Share by Type (2021-2032) Figure 18. Industry Image Figure 19. Medicine Image Figure 20. Basic Biological Research Tool Image Figure 21. Global Protease Sales Volume by Application (2021 VS 2025 VS 2032) & (Tons) Figure 22. Global Protease Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Protease Sales Volume Share by Application (2021-2032) Figure 24. Global Protease Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Protease Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Protease Sales Value Share by Application (2021-2032) Figure 27. Global Protease Sales by Region: 2021 VS 2025 VS 2032 (Tons) Figure 28. Global Protease Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Protease Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Protease Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Protease Sales Value (2021-2032) & (US$ Million) Figure 32. North America Protease Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Protease Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Protease Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Protease Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Protease Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Protease Sales Value (2021-2032) & (US$ Million) Figure 38. South America Protease Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Protease Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Protease Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Protease Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Protease Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Protease Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Protease Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Protease Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Microbial Source
  • Plant Source
  • Animal Source
Applications
  • Industry
  • Medicine
  • Basic Biological Research Tool
Companies covered
  • Novozymes A/S
  • DuPont (Danisco)
  • AB Enzymes
  • DSM
  • Aum Enzymes
  • BASF
  • Specialty Enzymes & Biotechnologies Co.
  • Jiangsu Boli Bioproducts Co., Ltd
  • Amano Enzymes, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Protease Sales Value (2021-2032)
  4. 1.2.2 Global Protease Sales Volume (2021-2032)
  5. 1.2.3 Global Protease Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Protease Market Dynamics
  1. 2.1 Protease Industry Trends
  2. 2.2 Protease Industry Drivers
  3. 2.3 Protease Industry Opportunities and Challenges
  4. 2.4 Protease Industry Restraints
3 Protease Market by Company
  1. 3.1 Global Protease Company Revenue Ranking in 2025
  2. 3.2 Global Protease Revenue by Company (2021-2026)
  3. 3.3 Global Protease Sales Volume by Company (2021-2026)
  4. 3.4 Global Protease Average Price by Company (2021-2026)
  5. 3.5 Global Protease Company Ranking (2024-2026)
  6. 3.6 Global Protease Company Manufacturing Base and Headquarters
  7. 3.7 Global Protease Company Product Type and Application
  8. 3.8 Global Protease Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Protease Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Protease Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Protease Market by Type
  1. 4.1 Protease Type Introduction
  2. 4.1.1 Microbial Source
  3. 4.1.2 Plant Source
  4. 4.1.3 Animal Source
  5. 4.2 Global Protease Sales Volume by Type
  6. 4.2.1 Global Protease Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Protease Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Protease Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Protease Sales Value by Type
  10. 4.3.1 Global Protease Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Protease Sales Value by Type (2021-2032)
  12. 4.3.3 Global Protease Sales Value Share by Type (2021-2032)
5 Protease Market by Application
  1. 5.1 Protease Application Introduction
  2. 5.1.1 Industry
  3. 5.1.2 Medicine
  4. 5.1.3 Basic Biological Research Tool
  5. 5.2 Global Protease Sales Volume by Application
  6. 5.2.1 Global Protease Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Protease Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Protease Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Protease Sales Value by Application
  10. 5.3.1 Global Protease Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Protease Sales Value by Application (2021-2032)
  12. 5.3.3 Global Protease Sales Value Share by Application (2021-2032)
6 Protease Regional Sales and Value Analysis
  1. 6.1 Global Protease Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Protease Sales by Region (2021-2032)
  3. 6.2.1 Global Protease Sales by Region: 2021-2026
  4. 6.2.2 Global Protease Sales by Region (2027-2032)
  5. 6.3 Global Protease Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Protease Sales Value by Region (2021-2032)
  7. 6.4.1 Global Protease Sales Value by Region: 2021-2026
  8. 6.4.2 Global Protease Sales Value by Region (2027-2032)
  9. 6.5 Global Protease Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Protease Sales Value (2021-2032)
  12. 6.6.2 North America Protease Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Protease Sales Value (2021-2032)
  15. 6.7.2 Europe Protease Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Protease Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Protease Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Protease Sales Value (2021-2032)
  21. 6.9.2 South America Protease Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Protease Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Protease Sales Value Share by Country, 2025 VS 2032
7 Protease Country-level Sales and Value Analysis
  1. 7.1 Global Protease Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Protease Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Protease Sales by Country (2021-2032)
  4. 7.3.1 Global Protease Sales by Country (2021-2026)
  5. 7.3.2 Global Protease Sales by Country (2027-2032)
  6. 7.4 Global Protease Sales Value by Country (2021-2032)
  7. 7.4.1 Global Protease Sales Value by Country (2021-2026)
  8. 7.4.2 Global Protease Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Protease Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Protease Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Protease Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Protease Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Protease Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Protease Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Protease Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Protease Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Protease Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Protease Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Protease Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Protease Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Protease Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Protease Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Protease Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Protease Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Protease Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Protease Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Protease Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Protease Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Protease Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Protease Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Protease Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Protease Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Protease Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Protease Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Protease Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Protease Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Protease Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Protease Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Protease Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Protease Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Protease Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Protease Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Protease Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Protease Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Protease Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Protease Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Protease Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Protease Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Protease Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Protease Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Protease Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Protease Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Protease Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Protease Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Protease Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Protease Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Protease Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Protease Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Protease Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Protease Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Protease Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Protease Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Protease Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Protease Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Protease Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Protease Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Protease Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Protease Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Protease Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Protease Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Protease Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Protease Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Protease Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Protease Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Protease Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Protease Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Protease Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Protease Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Protease Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Protease Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Protease Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Protease Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Protease Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Protease Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Protease Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Protease Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Protease Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Protease Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Protease Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Protease Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Protease Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Protease Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novozymes A/S
  2. 8.1.1 Novozymes A/S Company Information
  3. 8.1.2 Novozymes A/S Business Overview
  4. 8.1.3 Novozymes A/S Protease Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novozymes A/S Protease Product Portfolio
  6. 8.1.5 Novozymes A/S Recent Developments
  7. 8.2 DuPont (Danisco)
  8. 8.2.1 DuPont (Danisco) Company Information
  9. 8.2.2 DuPont (Danisco) Business Overview
  10. 8.2.3 DuPont (Danisco) Protease Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 DuPont (Danisco) Protease Product Portfolio
  12. 8.2.5 DuPont (Danisco) Recent Developments
  13. 8.3 AB Enzymes
  14. 8.3.1 AB Enzymes Company Information
  15. 8.3.2 AB Enzymes Business Overview
  16. 8.3.3 AB Enzymes Protease Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 AB Enzymes Protease Product Portfolio
  18. 8.3.5 AB Enzymes Recent Developments
  19. 8.4 DSM
  20. 8.4.1 DSM Company Information
  21. 8.4.2 DSM Business Overview
  22. 8.4.3 DSM Protease Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 DSM Protease Product Portfolio
  24. 8.4.5 DSM Recent Developments
  25. 8.5 Aum Enzymes
  26. 8.5.1 Aum Enzymes Company Information
  27. 8.5.2 Aum Enzymes Business Overview
  28. 8.5.3 Aum Enzymes Protease Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Aum Enzymes Protease Product Portfolio
  30. 8.5.5 Aum Enzymes Recent Developments
  31. 8.6 BASF
  32. 8.6.1 BASF Company Information
  33. 8.6.2 BASF Business Overview
  34. 8.6.3 BASF Protease Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 BASF Protease Product Portfolio
  36. 8.6.5 BASF Recent Developments
  37. 8.7 Specialty Enzymes & Biotechnologies Co.
  38. 8.7.1 Specialty Enzymes & Biotechnologies Co. Company Information
  39. 8.7.2 Specialty Enzymes & Biotechnologies Co. Business Overview
  40. 8.7.3 Specialty Enzymes & Biotechnologies Co. Protease Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Specialty Enzymes & Biotechnologies Co. Protease Product Portfolio
  42. 8.7.5 Specialty Enzymes & Biotechnologies Co. Recent Developments
  43. 8.8 Jiangsu Boli Bioproducts Co., Ltd
  44. 8.8.1 Jiangsu Boli Bioproducts Co., Ltd Company Information
  45. 8.8.2 Jiangsu Boli Bioproducts Co., Ltd Business Overview
  46. 8.8.3 Jiangsu Boli Bioproducts Co., Ltd Protease Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Jiangsu Boli Bioproducts Co., Ltd Protease Product Portfolio
  48. 8.8.5 Jiangsu Boli Bioproducts Co., Ltd Recent Developments
  49. 8.9 Amano Enzymes, Inc.
  50. 8.9.1 Amano Enzymes, Inc. Company Information
  51. 8.9.2 Amano Enzymes, Inc. Business Overview
  52. 8.9.3 Amano Enzymes, Inc. Protease Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Amano Enzymes, Inc. Protease Product Portfolio
  54. 8.9.5 Amano Enzymes, Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Protease Value Chain Analysis
  2. 9.1.1 Protease Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Protease Sales Mode & Process
  6. 9.2 Protease Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Protease Distributors
  9. 9.2.3 Protease Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst